Nexgenrx Inc (NXG.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,266 | 1,308 | 1,406 | 1,335 | 937 |
| Income taxes - deferred | 365 | 11 | 176 | -2,023 | -299 |
| Accounts receivable | -40 | -467 | 69 | -124 | 9 |
| Accounts payable and accrued liabilities | -679 | 260 | -492 | 536 | -282 |
| Other Working Capital | -1,140 | 229 | -582 | 425 | -287 |
| Other Operating Activity | 1,377 | -64 | 490 | 3,675 | 2,575 |
| Operating Cash Flow | $1,150 | $1,277 | $1,066 | $3,824 | $2,653 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -86 | -77 | -389 | -127 | -121 |
| Purchase Sale Intangibles | -232 | -171 | -118 | -1,243 | -957 |
| Other Investing Activity | -181 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-498 | $-248 | $-507 | $-1,370 | $-1,078 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -102 | -79 | -208 | -809 | -1,336 |
| Common Stock Issued | 188 | 63 | N/A | N/A | N/A |
| Dividend Paid | -908 | -902 | -901 | -130 | -65 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 100 |
| Financing Cash Flow | $-823 | $-919 | $-1,110 | $-940 | $-1,301 |
| Beginning Cash Position | 1,877 | 1,767 | 2,317 | 802 | 527 |
| End Cash Position | 1,706 | 1,877 | 1,767 | 2,317 | 802 |
| Net Cash Flow | $-171 | $110 | $-550 | $1,515 | $275 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,150 | 1,277 | 1,066 | 3,824 | 2,653 |
| Capital Expenditure | -318 | -248 | -507 | -1,370 | -1,078 |
| Free Cash Flow | 833 | 1,029 | 559 | 2,455 | 1,575 |